Literature DB >> 3384998

Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinomas.

S C Henzen-Logmans1, N W Schipper, L G Poels, K Stolk, P Kenemans, C J Meyer.   

Abstract

A study was carried out to determine whether it was possible to classify colonic and ovarian adenocarcinomas by their antigen profile. Colonic and ovarian adenocarcinomas were immunostained with a panel of antibodies which have a limited specificity for colon (parlam-4, 19.9, anti-secretory component) and ovary (OV-TL3 and OC125) and the most discriminatory antibodies were selected by stepwise linear discriminant analysis. For frozen material OV-TL3 and OC125 were the best classifying antibodies. Although OC125 had better discriminative power, for paraffin wax embedded material parlam-4 was selected as the best classifying antibody. OC125 had no additional effect on the classification of a tumour. These antibodies were subsequently tested on an independent test set of primary and metastatic adenocarcinomas of colonic and ovarian origin. When ovarian posterior probabilities of less than 0.1 and greater than 0.9 were selected as cut off points for a positive identification of colonic or ovarian origin (jackknifed classification method), no adenocarcinoma was incorrectly identified as ovarian carcinoma in frozen material. The same trend was noticed for paraffin wax embedded material. Statistical analysis of antigen profiles can be helpful in defining the colonic or ovarian origin of an adenocarcinoma when routine microscopy does not yield a definitive result.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384998      PMCID: PMC1141544          DOI: 10.1136/jcp.41.6.644

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies.

Authors:  C P Verstijnen; J W Arends; P T Moerkerk; S Warnaar; J Hilgers; F T Bosman
Journal:  Anticancer Res       Date:  1986 Jan-Feb       Impact factor: 2.480

2.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.

Authors:  M Herlyn; Z Steplewski; D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

3.  A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations.

Authors:  M Nuti; Y A Teramoto; R Mariani-Costantini; P H Hand; D Colcher; J Schlom
Journal:  Int J Cancer       Date:  1982-05-15       Impact factor: 7.396

4.  Monoclonal antibody against human ovarian tumor-associated antigens.

Authors:  L G Poels; D Peters; Y van Megen; G P Vooijs; R N Verheyen; A Willemen; C C van Niekerk; P H Jap; G Mungyer; P Kenemans
Journal:  J Natl Cancer Inst       Date:  1986-05       Impact factor: 13.506

5.  The value of tumour marker CA 125 in surgical pathology.

Authors:  I A Koelma; M Nap; C J Rodenburg; G J Fleuren
Journal:  Histopathology       Date:  1987-03       Impact factor: 5.087

6.  Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.

Authors:  S E Kabawat; R C Bast; W R Welch; R C Knapp; R B Colvin
Journal:  Am J Clin Pathol       Date:  1983-01       Impact factor: 2.493

7.  Novel antigenic specificity involving the blood group antigen, Lea, in combination with onco-developmental antigen, SSEA-1, recognized by two monoclonal antibodies to human milk-fat globule membranes.

Authors:  H C Gooi; N J Jones; E F Hounsell; P Scudder; J Hilkens; J Hilgers; T Feizi
Journal:  Biochem Biophys Res Commun       Date:  1985-09-16       Impact factor: 3.575

8.  Secretory component: a glandular epithelial cell marker.

Authors:  J P Harris; M A South
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

9.  Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors.

Authors:  J Hilkens; F Buijs; J Hilgers; P Hageman; J Calafat; A Sonnenberg; M van der Valk
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

10.  Thyroid-associated antigens in routinely embedded carcinomas. Possibilities and limitations studied in 116 cases.

Authors:  S C Logmans; A C Jöbsis
Journal:  Cancer       Date:  1984-07-15       Impact factor: 6.860

  10 in total
  3 in total

Review 1.  Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

2.  Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.

Authors:  J H Lagendijk; H Mullink; P J van Diest; G A Meijer; C J Meijer
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

3.  Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissue.

Authors:  M R Buist; C F Molthoff; P Kenemans; C J Meijer
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.